Protagenic Therapeutics, Inc.
PTIX
$0.92
-$0.11-10.32%
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -963.60K | 5.08M | 2.21M | -869.50K | -5.06M |
| Total Depreciation and Amortization | 8.30K | 11.50K | 12.60K | 12.60K | 12.60K |
| Total Amortization of Deferred Charges | -- | 1.32M | 0.00 | 0.00 | 243.40K |
| Total Other Non-Cash Items | 80.30K | -7.01M | -3.02M | -97.50K | 2.60M |
| Change in Net Operating Assets | -69.30K | 856.90K | 283.10K | -441.00K | 448.30K |
| Cash from Operations | -944.30K | 265.50K | -509.70K | -1.40M | -1.75M |
| Capital Expenditure | -- | -3.30K | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -310.00K | 0.00 | 0.00 | 943.20K |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -313.30K | 0.00 | 0.00 | 943.20K |
| Total Debt Issued | -- | 0.00 | 0.00 | -15.40K | 661.60K |
| Total Debt Repaid | -- | -533.90K | -- | -- | -- |
| Issuance of Common Stock | -- | 0.00 | -- | 0.00 | 4.35M |
| Repurchase of Common Stock | -- | -- | 0.00 | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -- | -533.90K | 0.00 | -15.40K | 5.01M |
| Foreign Exchange rate Adjustments | 1.10K | -121.80K | -100.00 | 37.10K | -117.20K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -943.20K | -703.50K | -509.80K | -1.37M | 4.08M |